Literature DB >> 22621672

Disruption of gallbladder smooth muscle function is an early feature in the development of cholesterol gallstone disease.

B Lavoie1, B Nausch, E A Zane, M R Leonard, O B Balemba, A C Bartoo, R Wilcox, M T Nelson, M C Carey, G M Mawe.   

Abstract

UNLABELLED: BACKGROUND; Decreased gallbladder smooth muscle (GBSM) contractility is a hallmark of cholesterol gallstone disease, but the interrelationship between lithogenicity, biliary stasis, and inflammation are poorly understood. We studied a mouse model of gallstone disease to evaluate the development of GBSM dysfunction relative to changes in bile composition and the onset of sterile cholecystitis.
METHODS: BALB/cJ mice were fed a lithogenic diet for up to 8 weeks, and tension generated by gallbladder muscle strips was measured. Smooth muscle Ca(2+) transients were imaged in intact gallbladder. KEY
RESULTS: Lipid composition of bile was altered lithogenically as early as 1 week, with increased hydrophobicity and cholesterol saturation indexes; however, inflammation was not detectable until the fourth week. Agonist-induced contractility was reduced from weeks 2 through 8. GBSM normally exhibits rhythmic synchronized Ca(2+) flashes, and their frequency is increased by carbachol (3 μm). After 1 week, lithogenic diet-fed mice exhibited disrupted Ca(2+) flash activity, manifesting as clustered flashes, asynchronous flashes, or prolonged quiescent periods. These changes could lead to a depletion of intracellular Ca(2+) stores, which are required for agonist-induced contraction, and diminished basal tone of the organ. Responsiveness of Ca(2+) transients to carbachol was reduced in mice on the lithogenic diet, particularly after 4-8 weeks, concomitant with appearance of mucosal inflammatory changes. CONCLUSIONS & INFERENCES: These observations demonstrate that GBSM dysfunction is an early event in the progression of cholesterol gallstone disease and that it precedes mucosal inflammation.
© 2012 Blackwell Publishing Ltd.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 22621672      PMCID: PMC3378777          DOI: 10.1111/j.1365-2982.2012.01935.x

Source DB:  PubMed          Journal:  Neurogastroenterol Motil        ISSN: 1350-1925            Impact factor:   3.598


  47 in total

1.  Abnormalities of gallbladder muscle associated with acute inflammation in guinea pigs.

Authors:  Z L Xiao; Q Chen; P Biancani; J Behar
Journal:  Am J Physiol Gastrointest Liver Physiol       Date:  2001-08       Impact factor: 4.052

2.  Gallbladder muscle dysfunction in patients with chronic acalculous disease.

Authors:  J Amaral; Z L Xiao; Q Chen; P Yu; P Biancani; J Behar
Journal:  Gastroenterology       Date:  2001-02       Impact factor: 22.682

3.  Phenotypic characterization of Lith genes that determine susceptibility to cholesterol cholelithiasis in inbred mice: soluble pronucleating proteins in gallbladder and hepatic biles.

Authors:  K J van Erpecum; D Q Wang; F Lammert; B Paigen; A K Groen; M C Carey
Journal:  J Hepatol       Date:  2001-10       Impact factor: 25.083

4.  Aging impairs Ca2+ sensitization pathways in gallbladder smooth muscle.

Authors:  Beatriz Macias; Pedro J Gomez-Pinilla; Cristina Camello-Almaraz; Patricia Pascua; Jesus Af Tresguerres; Pedro J Camello; Maria J Pozo
Journal:  Age (Dordr)       Date:  2011-07-12

5.  Defect of receptor-G protein coupling in human gallbladder with cholesterol stones.

Authors:  Z L Xiao; Q Chen; J Amaral; P Biancani; J Behar
Journal:  Am J Physiol Gastrointest Liver Physiol       Date:  2000-02       Impact factor: 4.052

6.  Cholesterol inhibits spontaneous action potentials and calcium currents in guinea pig gallbladder smooth muscle.

Authors:  L J Jennings; Q W Xu; T A Firth; M T Nelson; G M Mawe
Journal:  Am J Physiol       Date:  1999-11

7.  Effect of indomethacin on gallbladder inflammation and contractility during acute cholecystitis.

Authors:  H P Parkman; A N James; R M Thomas; L L Bartula; J P Ryan; S I Myers
Journal:  J Surg Res       Date:  2001-03       Impact factor: 2.192

Review 8.  Pathobiology of cholesterol gallstone disease: from equilibrium ternary phase diagram to agents preventing cholesterol crystallization and stone formation.

Authors:  Piero Portincasa; Antonio Moschetta; Giuseppe Calamita; Antonio Margari; Giuseppe Palasciano
Journal:  Curr Drug Targets Immune Endocr Metabol Disord       Date:  2003-03

9.  Hydrophilic but not hydrophobic bile acids prevent gallbladder muscle dysfunction in acute cholecystitis.

Authors:  Zuo-Liang Xiao; Piero Biancani; Martin C Carey; Jose Behar
Journal:  Hepatology       Date:  2003-06       Impact factor: 17.425

10.  Effects of bile acids on the muscle functions of guinea pig gallbladder.

Authors:  Zuo-Liang Xiao; Aloysius K Rho; Piero Biancani; Jose Behar
Journal:  Am J Physiol Gastrointest Liver Physiol       Date:  2002-07       Impact factor: 4.052

View more
  16 in total

Review 1.  The inflammatory inception of gallbladder cancer.

Authors:  Jaime A Espinoza; Carolina Bizama; Patricia García; Catterina Ferreccio; Milind Javle; Juan F Miquel; Jill Koshiol; Juan C Roa
Journal:  Biochim Biophys Acta       Date:  2016-03-12

Review 2.  An update on the pathogenesis of cholesterol gallstone disease.

Authors:  Agostino Di Ciaula; David Q-H Wang; Piero Portincasa
Journal:  Curr Opin Gastroenterol       Date:  2018-03       Impact factor: 3.287

Review 3.  Cholesterol gallstone disease: focusing on the role of gallbladder.

Authors:  Yongsheng Chen; Jing Kong; Shuodong Wu
Journal:  Lab Invest       Date:  2014-12-15       Impact factor: 5.662

4.  Impaired cholecystokinin-induced gallbladder emptying incriminated in spontaneous "black" pigment gallstone formation in germfree Swiss Webster mice.

Authors:  Stephanie E Woods; Monika R Leonard; Joshua A Hayden; Megan Brunjes Brophy; Kara R Bernert; Brigitte Lavoie; Sureshkumar Muthupalani; Mark T Whary; Gary M Mawe; Elizabeth M Nolan; Martin C Carey; James G Fox
Journal:  Am J Physiol Gastrointest Liver Physiol       Date:  2014-12-04       Impact factor: 4.052

5.  Endogenous elevation of plasma cholecystokinin does not prevent gallstones.

Authors:  Rafiq A Shahid; David Q-H Wang; Brian E Fee; Shannon J McCall; Joelle M-J Romac; Steven R Vigna; Rodger A Liddle
Journal:  Eur J Clin Invest       Date:  2015-03       Impact factor: 4.686

6.  Biliary Polyunsaturated Fatty Acids and Telocytes in Gallstone Disease.

Authors:  Artur Pasternak; Jolanta Bugajska; Mirosław Szura; Jerzy A Walocha; Andrzej Matyja; Mariusz Gajda; Krystyna Sztefko; Krzysztof Gil
Journal:  Cell Transplant       Date:  2016-08-05       Impact factor: 4.064

7.  Prevention of gallbladder hypomotility via FATP2 inhibition protects from lithogenic diet-induced cholelithiasis.

Authors:  Kevin M Tharp; Amin Khalifeh-Soltani; Hyo Min Park; David A Yurek; Alaric Falcon; Louis Wong; Rouying Feng; Kamran Atabai; Andreas Stahl
Journal:  Am J Physiol Gastrointest Liver Physiol       Date:  2016-03-31       Impact factor: 4.052

Review 8.  Telocytes and interstitial cells of Cajal in the biliary system.

Authors:  Lei Chen; Baoping Yu
Journal:  J Cell Mol Med       Date:  2018-04-26       Impact factor: 5.310

9.  Telocytes: new insight into the pathogenesis of gallstone disease.

Authors:  Andrzej Matyja; Krzysztof Gil; Artur Pasternak; Krystyna Sztefko; Mariusz Gajda; Krzysztof A Tomaszewski; Maciej Matyja; Jerzy A Walocha; Jan Kulig; Piotr Thor
Journal:  J Cell Mol Med       Date:  2013-04-04       Impact factor: 5.310

10.  Histopathological analysis of Salmonella chronic carriage in the mouse hepatopancreatobiliary system.

Authors:  Geoffrey Gonzalez-Escobedo; Krista M D La Perle; John S Gunn
Journal:  PLoS One       Date:  2013-12-12       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.